跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
2'-Deoxycytidine
首页
药物
2'-Deoxycytidine
Experimental
Small Molecule
2'-Deoxycytidine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
9
H
13
N
3
O
4
CAS 编号
951-77-9
UNII ID
0W860991D6
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
EP 3310362 B1
申请人: UNIV COLUMBIA
优先权: 2015
CN
EP
US
WO
15 件公开
Oligonucleotide analogues incorporating 5-aza-cytosine therein
US 7700567 B2
申请人: SUPERGEN INC
优先权: 2005
CN
US
10 件公开
Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US 7223744 B2
申请人: INSPIRE PHARMACEUTICALS INC
优先权: 2004
US
6 件公开
CARBOCYCLIC NUCLEOSIDE ANALOGUE
EP 3747872 A1
申请人: UNIV MUENCHEN LUDWIG MAXIMILIANS
优先权: 2019
CN
EP
US
WO
5 件公开
METHOD FOR PREPARING 4?-THIO-5-AZA-2?-DEOXYCYTIDINE
EP 4524145 A4
申请人: PINOTBIO INC
优先权: 2022
CN
EP
US
WO
4 件公开
Gemcitabine derivatives nanoparticles
US 2009130214 A1
申请人: COUVREUR PATRICK
优先权: 2004
CN
EP
US
4 件公开
COMBINED THERAPY OF 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND VENETOCLAX
EP 4316494 A4
申请人: PINOTBIO INC
优先权: 2021
EP
US
WO
4 件公开
Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy
US 9364494 B2
申请人: BUSCAIL LOUIS
优先权: 2007
EP
US
4 件公开
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US 2004166058 A1
申请人: UNIV TEXAS
优先权: 2002
CN
US
3 件公开
Composition for treating blood cancer using 4′-thio-5-Aza-2′-deoxycytidine and uses thereof
US 12208112 B2
申请人: SOUTHERN RES INST
优先权: 2020
CN
US
3 件公开
第 1 / 5 页
上一页
下一页
药物
反馈